Improving non-invasive ventilation for patients with acute respiratory failure
Official title: Improving Non Invasive Ventilation
Run by Università Vita-Salute San Raffaele · NCT01571986 · Data updated 2026-11-12
This study looks at how well non-invasive ventilation works for people with acute respiratory failure to help improve their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 750 (estimated) |
| Sponsor | Università Vita-Salute San Raffaele Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | February 2012 |
| Main results expected | May 2026 |
| Study ends | May 2026 |
| Registry record updated | July 1, 2025 |
| Trial ID | NCT01571986 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients currently receiving non-invasive ventilation for acute respiratory failure.
✕Probably not a fit
Patients who refuse informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance understanding of non-invasive ventilation (NIV) in patients experiencing acute respiratory failure. It will collect data on patient compliance, treatment efficacy, and imaging results for individuals already receiving NIV as part of their standard care. The study is conducted at a single center, focusing on gathering real-world evidence to inform future practices in managing respiratory failure.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with acute respiratory failure using non-invasive ventilation.
How similar studies have gone: While there have been studies on non-invasive ventilation, this specific observational approach to improve knowledge and compliance is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * treatment with non-invasive ventilation * informed consent Exclusion Criteria: * refusal of informed consent
Where it's running
-
Ospedale San Raffaele di Milano
Milan, Italy Recruiting
Study contacts
- Study coordinator: Luca Cabrini, MD
- Email: cabrini.luca@hsr.it
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sodium bicarbonate with bedside electrical impedance tomography to map lung blood flow in ventilated adults
This project will try whether a small sodium bicarbonate injection combined with bedside electrical impedance tomography can map lung blood flow in adults on mechanical ventilation, compared with hypertonic saline.
-
Feasibility of using a weight-adjusted saline bolus with electrical impedance tomography to map lung perfusion in children
This pediatric pilot tests whether a carefully dosed saline bolus with electrical impedance tomography can map lung perfusion and ventilation distribution in kids with acute respiratory failure.
-
Predicting HFNO failure within 72 hours using a physiology-informed model at 30 minutes
This study tests a model that uses Heart–lung physiology and 30-minute data to see if high-flow nasal oxygen will fail in adults with acute hypoxemic respiratory failure.
-
Bedside ultrasound of the IVC to find pulmonary edema in adults with sudden severe breathlessness
This project will test whether bedside ultrasound measurements of how the inferior vena cava changes with breathing can help identify pulmonary edema in adults who come to the emergency department with sudden breathing failure.
-
Brain–lung interaction during sudden severe low-oxygen respiratory failure
We will try EEG, NIRS, and neck muscle recordings before and one hour after starting high-flow nasal oxygen in adults with sudden low-oxygen respiratory failure to see how the brain and lungs interact.
-
Comparing SpO2 targets and oximeters during high-flow nasal oxygen
This study tests whether two different pulse oximeters (Nonin and Philips) and two SpO2 targets (90% vs 94%) change the amount of oxygen (FiO2) set for adults in the ICU receiving high-flow nasal oxygen.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.